Literature DB >> 26202908

Gold(I) NHC-based homo- and heterobimetallic complexes: synthesis, characterization and evaluation as potential anticancer agents.

Benoît Bertrand1, Anna Citta, Inge L Franken, Michel Picquet, Alessandra Folda, Valeria Scalcon, Maria Pia Rigobello, Pierre Le Gendre, Angela Casini, Ewen Bodio.   

Abstract

While N-heterocyclic carbenes (NHC) are ubiquitous ligands in catalysis for organic or industrial syntheses, their potential to form transition metal complexes for medicinal applications has still to be exploited. Within this frame, we synthesized new homo- and heterobimetallic complexes based on the Au(I)-NHC scaffold. The compounds were synthesized via a microwave-assisted method developed in our laboratories using Au(I)-NHC complexes carrying a pentafluorophenol ester moiety and another Au(I) phosphane complex or a bipyridine ligand bearing a pendant amine function. Thus, we developed two different methods to prepare homo- and heterobimetallic complexes (Au(I)/Au(I) or Au(I)/Cu(II), Au(I)/Ru(II), respectively). All the compounds were fully characterized by several spectroscopic techniques including far infrared, and were tested for their antiproliferative effects in a series of human cancer cells. They showed moderate anticancer properties. Their toxic effects were also studied ex vivo using the precision-cut tissue slices (PCTS) technique and initial results concerning their reactivity with the seleno-enzyme thioredoxin reductase were obtained.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26202908     DOI: 10.1007/s00775-015-1283-1

Source DB:  PubMed          Journal:  J Biol Inorg Chem        ISSN: 0949-8257            Impact factor:   3.358


  59 in total

1.  Preparation and incubation of precision-cut liver and intestinal slices for application in drug metabolism and toxicity studies.

Authors:  Inge A M de Graaf; Peter Olinga; Marina H de Jager; Marjolijn T Merema; Ruben de Kanter; Esther G van de Kerkhof; Geny M M Groothuis
Journal:  Nat Protoc       Date:  2010-08-19       Impact factor: 13.491

Review 2.  Advances in copper complexes as anticancer agents.

Authors:  Carlo Santini; Maura Pellei; Valentina Gandin; Marina Porchia; Francesco Tisato; Cristina Marzano
Journal:  Chem Rev       Date:  2013-10-08       Impact factor: 60.622

3.  Cellular uptake, cytotoxicity, apoptosis, DNA-binding, photocleavage and molecular docking studies of ruthenium(II) polypyridyl complexes.

Authors:  A Srishailam; Yata Praveen Kumar; P Venkat Reddy; Navaneetha Nambigari; Uma Vuruputuri; Surya S Singh; S Satyanarayana
Journal:  J Photochem Photobiol B       Date:  2014-02-18       Impact factor: 6.252

Review 4.  Metal complex SERMs (selective oestrogen receptor modulators). The influence of different metal units on breast cancer cell antiproliferative effects.

Authors:  Anne Vessières; Siden Top; Wolfgang Beck; Elizabeth Hillard; Gérard Jaouen
Journal:  Dalton Trans       Date:  2005-09-27       Impact factor: 4.390

5.  Emerging protein targets for anticancer metallodrugs: inhibition of thioredoxin reductase and cathepsin B by antitumor ruthenium(II)-arene compounds.

Authors:  Angela Casini; Chiara Gabbiani; Francesca Sorrentino; Maria Pia Rigobello; Alberto Bindoli; Tilmann J Geldbach; Alessandro Marrone; Nazzareno Re; Christian G Hartinger; Paul J Dyson; Luigi Messori
Journal:  J Med Chem       Date:  2008-10-04       Impact factor: 7.446

6.  A gold(I) phosphine complex containing a naphthalimide ligand functions as a TrxR inhibiting antiproliferative agent and angiogenesis inhibitor.

Authors:  Ingo Ott; Xuhong Qian; Yufang Xu; Danielle H W Vlecken; Ines J Marques; Dominic Kubutat; Joanna Will; William S Sheldrick; Patrick Jesse; Aram Prokop; Christoph P Bagowski
Journal:  J Med Chem       Date:  2009-02-12       Impact factor: 7.446

Review 7.  Focus on mammalian thioredoxin reductases--important selenoproteins with versatile functions.

Authors:  Elias S J Arnér
Journal:  Biochim Biophys Acta       Date:  2009-02-11

8.  Visible light-absorbing rhenium(I) tricarbonyl complexes as triplet photosensitizers in photooxidation and triplet-triplet annihilation upconversion.

Authors:  Xiuyu Yi; Jianzhang Zhao; Jifu Sun; Song Guo; Hongli Zhang
Journal:  Dalton Trans       Date:  2013-02-14       Impact factor: 4.390

9.  Mitochondria-targeted chemotherapeutics: the rational design of gold(I) N-heterocyclic carbene complexes that are selectively toxic to cancer cells and target protein selenols in preference to thiols.

Authors:  James L Hickey; Rasha A Ruhayel; Peter J Barnard; Murray V Baker; Susan J Berners-Price; Aleksandra Filipovska
Journal:  J Am Chem Soc       Date:  2008-08-26       Impact factor: 15.419

Review 10.  Anticancer activity of metal complexes: involvement of redox processes.

Authors:  Ute Jungwirth; Christian R Kowol; Bernhard K Keppler; Christian G Hartinger; Walter Berger; Petra Heffeter
Journal:  Antioxid Redox Signal       Date:  2011-05-11       Impact factor: 8.401

View more
  9 in total

1.  Ex vivo toxicological evaluation of experimental anticancer gold(i) complexes with lansoprazole-type ligands.

Authors:  Natalia Estrada-Ortiz; Elena Lopez-Gonzales; Ben Woods; Stefan Stürup; Inge A M de Graaf; Geny M M Groothuis; Angela Casini
Journal:  Toxicol Res (Camb)       Date:  2019-09-20       Impact factor: 3.524

2.  A heterometallic ruthenium-gold complex displays antiproliferative, antimigratory, and antiangiogenic properties and inhibits metastasis and angiogenesis-associated proteases in renal cancer.

Authors:  Benelita T Elie; Yuriy Pechenyy; Fathema Uddin; María Contel
Journal:  J Biol Inorg Chem       Date:  2018-03-05       Impact factor: 3.358

3.  Versatile synthesis of cationic N-heterocyclic carbene-gold(i) complexes containing a second ancillary ligand. Design of heterobimetallic ruthenium-gold anticancer agents.

Authors:  Jacob Fernández-Gallardo; Benelita T Elie; Mercedes Sanaú; María Contel
Journal:  Chem Commun (Camb)       Date:  2016-02-21       Impact factor: 6.222

4.  Biscarbene gold(i) complexes: structure-activity-relationships regarding antibacterial effects, cytotoxicity, TrxR inhibition and cellular bioavailability.

Authors:  Claudia Schmidt; Bianka Karge; Rainer Misgeld; Aram Prokop; Mark Brönstrup; Ingo Ott
Journal:  Medchemcomm       Date:  2017-06-27       Impact factor: 3.597

5.  Bimetallic titanocene-gold phosphane complexes inhibit invasion, metastasis, and angiogenesis-associated signaling molecules in renal cancer.

Authors:  Benelita T Elie; Jacob Fernández-Gallardo; Natalia Curado; Mike A Cornejo; Joe W Ramos; María Contel
Journal:  Eur J Med Chem       Date:  2018-10-17       Impact factor: 6.514

6.  Targeting Telomeres: Molecular Dynamics and Free Energy Simulation of Gold-Carbene Binding to DNA.

Authors:  Asmar Nayis; Korbinian Liebl; Christina V Frost; Martin Zacharias
Journal:  Biophys J       Date:  2020-12-05       Impact factor: 4.033

7.  An Organometallic Gold(I) Bis-N-Heterocyclic Carbene Complex with Multimodal Activity in Ovarian Cancer Cells.

Authors:  Samuel M Meier-Menches; Benjamin Neuditschko; Katja Zappe; Martin Schaier; Marlene C Gerner; Klaus G Schmetterer; Giorgia Del Favero; Riccardo Bonsignore; Margit Cichna-Markl; Gunda Koellensperger; Angela Casini; Christopher Gerner
Journal:  Chemistry       Date:  2020-11-03       Impact factor: 5.236

Review 8.  Strategies for the Improvement of Metal-Based Chemotherapeutic Treatments.

Authors:  Damiano Cirri; Francesco Bartoli; Alessandro Pratesi; Emma Baglini; Elisabetta Barresi; Tiziano Marzo
Journal:  Biomedicines       Date:  2021-05-04

9.  Titanocene-Gold Complexes Containing N-Heterocyclic Carbene Ligands Inhibit Growth of Prostate, Renal, and Colon Cancers in Vitro.

Authors:  Yiu Fung Mui; Jacob Fernández-Gallardo; Benelita T Elie; Ahmed Gubran; Irene Maluenda; Mercedes Sanaú; Oscar Navarro; María Contel
Journal:  Organometallics       Date:  2016-04-15       Impact factor: 3.876

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.